These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7979286)

  • 1. Pharmacokinetics of zidovudine phosphorylation in peripheral blood mononuclear cells from patients infected with human immunodeficiency virus.
    Stretcher BN; Pesce AJ; Frame PT; Stein DS
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1541-7. PubMed ID: 7979286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentrations of phosphorylated zidovudine (ZDV) in patient leukocytes do not correlate with ZDV dose or plasma concentrations.
    Stretcher BN; Pesce AJ; Murray JA; Hurtubise PE; Vine WH; Frame PT
    Ther Drug Monit; 1991 Jul; 13(4):325-31. PubMed ID: 1780965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of zidovudine dose on the formation of intracellular phosphorylated metabolites.
    Barry MG; Khoo SH; Veal GJ; Hoggard PG; Gibbons SE; Wilkins EG; Williams O; Breckenridge AM; Back DJ
    AIDS; 1996 Oct; 10(12):1361-7. PubMed ID: 8902065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylated zidovudine concentrations in mononuclear cells in pediatric patients with human immunodeficiency virus infections.
    Wintermeyer SM; Nahata MC; Brady MT; Sobol BJ; Venglarcik JS 3rd ; Baker RC; Hunkler JA; McOwen NM
    Pediatr AIDS HIV Infect; 1997 Apr; 8(2):120-6. PubMed ID: 11361778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlates of zidovudine phosphorylation with markers of HIV disease progression and drug toxicity.
    Stretcher BN; Pesce AJ; Frame PT; Greenberg KA; Stein DS
    AIDS; 1994 Jun; 8(6):763-9. PubMed ID: 8086134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular pharmacokinetics of once versus twice daily zidovudine and lamivudine in adolescents.
    Flynn PM; Rodman J; Lindsey JC; Robbins B; Capparelli E; Knapp KM; Rodriguez JF; McNamara J; Serchuck L; Heckman B; Martinez J;
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3516-22. PubMed ID: 17664328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous and oral zidovudine pharmacokinetics and coagulation effects in asymptomatic human immunodeficiency virus-infected hemophilia patients.
    Morse GD; Portmore AC; Marder V; Plank C; Olson J; Taylor C; Bonnez W; Reichman RC
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2245-52. PubMed ID: 1444306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s Study Team.
    Aweeka FT; Kang M; Yu JY; Lizak P; Alston B; Chung RT;
    HIV Med; 2007 Jul; 8(5):288-94. PubMed ID: 17561874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and bioavailability of zidovudine and its glucuronidated metabolite in patients with human immunodeficiency virus infection and hepatic disease (AIDS Clinical Trials Group protocol 062).
    Moore KH; Raasch RH; Brouwer KL; Opheim K; Cheeseman SH; Eyster E; Lemon SM; van der Horst CM
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2732-7. PubMed ID: 8593010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of zidovudine phosphorylation in human immunodeficiency virus-positive thai patients and healthy volunteers.
    Wattanagoon Y; Na Bangchang K; Hoggard PG; Khoo SH; Gibbons SE; Phiboonbhanakit D; Karbwang J; Back DJ
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1986-9. PubMed ID: 10858368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzymatic assay for measurement of zidovudine triphosphate in peripheral blood mononuclear cells.
    Robbins BL; Rodman J; McDonald C; Srinivas RV; Flynn PM; Fridland A
    Antimicrob Agents Chemother; 1994 Jan; 38(1):115-21. PubMed ID: 7511360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-dose pharmacokinetics and safety of abacavir (1592U89), zidovudine, and lamivudine administered alone and in combination in adults with human immunodeficiency virus infection.
    Wang LH; Chittick GE; McDowell JA
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1708-15. PubMed ID: 10390227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the steady-state pharmacokinetics and safety of abacavir, lamivudine, and zidovudine taken as a triple combination tablet and as abacavir plus a lamivudine-zidovudine double combination tablet by HIV-1-infected adults.
    Crémieux AC; Katlama C; Gillotin C; Demarles D; Yuen GJ; Raffi F;
    Pharmacotherapy; 2001 Apr; 21(4):424-30. PubMed ID: 11310515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients. The National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators.
    Zhou XJ; Sheiner LB; D'Aquila RT; Hughes MD; Hirsch MS; Fischl MA; Johnson VA; Myers M; Sommadossi JP
    Antimicrob Agents Chemother; 1999 Jan; 43(1):121-8. PubMed ID: 9869576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zidovudine phosphorylation in HIV-infected patients and seronegative volunteers.
    Barry M; Wild M; Veal G; Back D; Breckenridge A; Fox R; Beeching N; Nye F; Carey P; Timmins D
    AIDS; 1994 Aug; 8(8):F1-5. PubMed ID: 7986398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular zidovudine (ZDV) and ZDV phosphates as measured by a validated combined high-pressure liquid chromatography-radioimmunoassay procedure.
    Slusher JT; Kuwahara SK; Hamzeh FM; Lewis LD; Kornhauser DM; Lietman PS
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2473-7. PubMed ID: 1489190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of zidovudine after rectal administration in human immunodeficiency virus-infected patients.
    Wintergerst U; Rolinski B; Bogner JR; Notheis G; Goebel FD; Roscher AA; Belohradsky BH
    Antimicrob Agents Chemother; 1997 May; 41(5):1143-5. PubMed ID: 9145885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple-dose pharmacokinetics of oral zidovudine in hemophilia patients with human immunodeficiency virus infection.
    Morse GD; Portmore A; Olson J; Taylor C; Plank C; Reichman RC
    Antimicrob Agents Chemother; 1990 Mar; 34(3):394-7. PubMed ID: 2334151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of zidovudine phosphorylation in patients infected with the human immunodeficiency virus.
    Stretcher BN; Pesce AJ; Hurtubise PE; Frame PT
    Ther Drug Monit; 1992 Aug; 14(4):281-5. PubMed ID: 1519301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of orally administered zidovudine among patients with hemophilia and asymptomatic human immunodeficiency virus (HIV) infection.
    Morse GD; Olson J; Portmore A; Taylor C; Plank C; Reichman RC
    Antiviral Res; 1989 Mar; 11(2):57-65. PubMed ID: 2729955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.